Clearside Biomedical Inc. (CLSD)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.93
0.01 (1.09%)
At close: Jan 15, 2025, 3:59 PM
0.94
1.08%
After-hours Jan 15, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 28.92M | 48.26M | 30.44M | 17.29M | 22.59M | 8.04M | 9.22M | 34.82M | 20.28M | 8.27M | 1.91M | 856.00K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 32.84M | 28.42M | 48.81M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 30.00K | 160.00K | 260.00K | 360.00K | 360.00K | 360.00K | 360.00K | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 30.00K | 1.14M | n/a | n/a | n/a | 26.00K | -885.00K | -94.00K | 417.00K | 1.77M | 22.00K | -50.00K |
Receivables | 170.00K | n/a | 10.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | 921.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.03M | 1.14M | 1.70M | 831.00K | 2.62M | 2.07M | 1.56M | 686.00K | 199.00K | 54.00K | 108.00K | 27.00K |
Total Current Assets | 30.12M | 48.26M | 42.14M | 18.12M | 25.22M | 42.94M | 37.64M | 83.63M | 20.48M | 8.32M | 2.02M | 883.00K |
Property-Plant & Equipment | 3.87M | 1.87M | 607.00K | 944.00K | 1.20M | 790.00K | 885.00K | 94.00K | 156.00K | 205.00K | 98.00K | 50.00K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.90M | 3.04M | 767.00K | 1.20M | 1.56M | 1.18M | 360.00K | 360.00K | 573.00K | 1.98M | 120.00K | 50.00K |
Total Assets | 34.02M | 51.30M | 42.90M | 19.32M | 26.78M | 44.12M | 40.49M | 84.81M | 21.05M | 10.30M | 2.14M | 948.00K |
Account Payables | 2.21M | 1.05M | 941.00K | 2.00M | 1.28M | 6.87M | 5.38M | 2.59M | 1.47M | 1.26M | 248.00K | n/a |
Deferred Revenue | 75.00K | 205.00K | n/a | 5.00M | 5.00M | n/a | 140.00K | 160.00K | n/a | n/a | n/a | n/a |
Short-Term Debt | 364.00K | 698.00K | 774.00K | 1.74M | 2.05M | 556.00K | 3.20M | n/a | 1.73M | n/a | n/a | n/a |
Other Current Liabilities | 4.17M | 3.83M | 2.92M | 1.21M | 2.57M | 3.05M | 4.93M | 2.81M | 1.99M | 1.17M | 435.00K | 529.00K |
Total Current Liabilities | 6.81M | 5.78M | 4.64M | 9.94M | 10.90M | 10.48M | 13.52M | 5.41M | 5.20M | 2.42M | 683.00K | 531.00K |
Long-Term Debt | 42.64M | 936.00K | 288.00K | 616.00K | 4.72M | 9.42M | 4.81M | 7.59M | 4.24M | n/a | 268.00K | 150.00K |
Other Long-Term Liabilities | 480.00K | 33.98M | n/a | n/a | n/a | 605.00K | 610.00K | n/a | 258.00K | 26.89M | 11.92M | n/a |
Total Long-Term Liabilities | 43.12M | 33.98M | 288.00K | 616.00K | 4.72M | 10.02M | 8.01M | 7.59M | 52.52M | 27.09M | 12.19M | 150.00K |
Total Liabilities | 49.93M | 40.70M | 4.93M | 10.56M | 15.62M | 20.50M | 19.08M | 13.15M | 57.71M | 29.51M | 12.88M | 709.00K |
Total Debt | 43.00M | 1.28M | 675.00K | 1.98M | 6.41M | 9.97M | 8.01M | 7.59M | 5.98M | n/a | 268.00K | n/a |
Common Stock | 63.00K | 61.00K | 60.00K | 52.00K | 44.00K | 32.00K | 25.00K | 25.00K | 3.00K | 4.00K | 3.00K | 2.00K |
Retained Earnings | -320.92M | -288.44M | -255.49M | -255.87M | -237.66M | -206.89M | -124.22M | -65.25M | -39.36M | -21.72M | -11.54M | -4.28M |
Comprehensive Income | n/a | n/a | n/a | 0.00 | n/a | n/a | -8.00K | -13.00K | -103.00K | -55.00K | -22.00K | n/a |
Shareholders Equity | -15.91M | 10.61M | 37.98M | 8.76M | 11.16M | 23.62M | 21.41M | 71.66M | -36.66M | -19.21M | -10.74M | 239.00K |
Total Investments | n/a | 30.00K | 160.00K | 260.00K | 360.00K | 32.84M | 28.42M | 48.81M | n/a | n/a | n/a | n/a |